Literature DB >> 11710118

Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers.

D Wang1, J P Kopecková, T Minko, V Nanayakkara, J Kopecek.   

Abstract

Starlike HPMA copolymers were synthesized by conjugating semitelechelic poly[N-(2-hydroxypropyl)-methacrylamide] macromolecules (ST-PHPMA, arm) with PAMAM dendrimers (core: G2, G3, G4). ST-PHPMA was synthesized by chain transfer free radical polymerization, and the terminal -COOH was activated with N-hydroxysuccinimide. Doxorubicin (DOX) was introduced into the starlike HPMA copolymer to evaluate its potential as a drug delivery system. The polymers were characterized with SEC, NMR, and UV. Cytotoxicity of the DOX containing starlike HPMA copolymer was determined on an A2780 human ovarian carcinoma cell line and compared with DOX-containing linear HPMA copolymers. The rate of in vitro DOX release from polymer--DOX conjugates in the presence of cathepsin B (CP-B, lysosomal cysteine proteinase) was determined and correlated with cytotoxicity results.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11710118     DOI: 10.1021/bm0000236

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  12 in total

1.  HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.

Authors:  Sarita Rani; Avinash Gothwal; Pawan K Pandey; Devendra S Chauhan; Praveen K Pachouri; Umesh D Gupta; Umesh Gupta
Journal:  Pharm Res       Date:  2018-12-03       Impact factor: 4.200

2.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

Review 3.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

4.  The Light at the End of the Tunnel-Second Generation HPMA Conjugates for Cancer Treatment.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  Curr Opin Colloid Interface Sci       Date:  2017-07-28       Impact factor: 6.448

Review 5.  Design of smart HPMA copolymer-based nanomedicines.

Authors:  Jiyuan Yang; Jindřich Kopeček
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

Review 6.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

7.  Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

Authors:  Maha Saad; Olga B Garbuzenko; Elizabeth Ber; Pooja Chandna; Jayant J Khandare; Vitaly P Pozharov; Tamara Minko
Journal:  J Control Release       Date:  2008-06-25       Impact factor: 9.776

8.  Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.

Authors:  Mark P Borgman; Abhijit Ray; Rohit B Kolhatkar; Edward A Sausville; Angelika M Burger; Hamidreza Ghandehari
Journal:  Pharm Res       Date:  2009-02-19       Impact factor: 4.200

9.  Binding properties of water-soluble carbosilane dendrimers.

Authors:  Elzbieta Pedziwiatr; Dzmitry Shcharbin; Louis Chonco; Paula Ortega; F Javier de la Mata; Rafael Gómez; Barbara Klajnert; Maria Bryszewska; Ma Angeles Muñoz-Fernandez
Journal:  J Fluoresc       Date:  2008-08-30       Impact factor: 2.217

10.  Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma.

Authors:  Sarah M Ward; Matthew Skinner; Banishree Saha; Todd Emrick
Journal:  Mol Pharm       Date:  2018-10-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.